213 related articles for article (PubMed ID: 32141552)
1. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.
Fu XY; Zhou WB; Xu J
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1829-1840. PubMed ID: 32141552
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
3. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
[TBL] [Abstract][Full Text] [Related]
4. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.
Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z
Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283
[TBL] [Abstract][Full Text] [Related]
5. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
7. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD
Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514
[TBL] [Abstract][Full Text] [Related]
8. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
[No Abstract] [Full Text] [Related]
9. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.
Ma YS; Yu F; Zhong XM; Lu GX; Cong XL; Xue SB; Xie WT; Hou LK; Pang LJ; Wu W; Zhang W; Cong LL; Liu T; Long HD; Sun R; Sun HY; Lv ZW; Wu CY; Fu D
Mol Ther; 2018 Dec; 26(12):2751-2765. PubMed ID: 30301667
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of TM4SF1 improves cell metastasis and growth by activating ERK1/2 signaling pathway in human prostate cancer.
Chen J; Wang F; Xu H; Chen D; Liu W; Wang J
J BUON; 2019; 24(6):2531-2538. PubMed ID: 31983129
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
13. m
Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
[TBL] [Abstract][Full Text] [Related]
14. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
15. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
17. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
18. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration.
Xu L; Li Q; Xu D; Wang Q; An Y; Du Q; Zhang J; Zhu Y; Miao Y
Int J Oncol; 2014 Feb; 44(2):459-66. PubMed ID: 24285464
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
20. Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway.
Wang YL; Wang Q; Li H; Wang CC; Ma YL; Han Z
Neoplasma; 2023 Feb; 70(1):46-57. PubMed ID: 36620877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]